Association between BanI genotype and increased phospholipase A2 activity in schizophrenia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 6, 2007, Pages 340-343

  Barbosa, Nadia R ^a   Junqueira, Ricardo M ^a   Vallada, Homero P ^a   Gattaz, Wagner F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BanI polymorphism; cPLA2; Phospholipase A2; PLA2G4A; Schizophrenia

Indexed keywords

PHOSPHOLIPASE A2;

ADULT; ALLELE; ARTICLE; BAN1 GENE; CHROMOSOME 1Q; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; RISK; SCHIZOPHRENIA; THROMBOCYTE;

ADULT; BLOOD PLATELETS; DATA INTERPRETATION, STATISTICAL; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTRONS; MALE; PHOSPHOLIPASES A2; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 34748858084     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-007-0736-0     Document Type: Article

References (31)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington, DC
2. Barradas MA, Mikhailidis DP (1993) The use of platelets as models for neurons: possible applications to the investigation of eating disorders. Biomed Pharmacother 47:11-18
3. Chowdari KV, Brandstaetter B, Semwal P, Bhatia T, Deshpande S, Reddy R, Wood J, Weinberg CR, Thelma BK, Nimgaonkar VL (2001) Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples. Psychiatr Genet 11:207-212
4. Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65:1043-1051
5. Di Luca M, Colciaghi F, Pastorino L, Borroni B, Padovani A, Cattabeni F (2000) Platelets as a peripheral district were to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol 405:277-283
6. Frieboes RM, Moises HW, Gattaz WF, Yang L, Li T, Liu X, Vetter P, Macciardi F, Hwu HG, Henn F (2001) Lack of association between schizophrenia and the phospholipase-A (2) genes cPLA2 and sPLA2. Am J Med Genet 105:246-249
7. 2 activity in schizophrenia: reduction after neuroleptic therapy. Biol Psychiatry 22:421-426
8. 2 activity in schizophrenia: a replication study. Biol Psychiatry 28:495-501
9. 2 activity in schizophrenia. Schizophr Res 16:1-6
10. Glen AI, Glen EM, Horrobin DF, Vaddadi KS, Spellman M, Morse-Fisher N, Ellis K, Skinner FS (1994) A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res 12:53-61
11. Horrobin DF (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30(3):193-208
12. Horrobin DF, Bennett CN (1999) New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 60:111-167
13. Hudson CJ, Kennedy JL, Gotowiec A, Lin A, King N, Gojtan K, Macciardi F, Skorecki K, Meltzer HY, Warsh JJ, Horrobin DF (1996) Genetic variant near cytosolic phospholipase A2 associated with schizophrenia. Schizophr Res; 21(2):111-116
14. Law MH, Cotton RGH, Berger GE (2006) The role of phospholipase A2 in schizophrenia. Mol Psychiatry 11:547-556
15. Miller SA, Dykes DD, Polesky HF (1988) A single salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215
16. Ott J (1988) Utility programs for analysis of genetic linkage. Columbia University, New York
17. Pae CU, Yu HS, Lee KU, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH (2004) BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:739-741
18. Peet M (1999) New strategies for the treatment of schizophrenia: omega-3 polyunsaturated fatty acids. In: Peet M, Glen I, Horronin DF (eds) Phospholipid spectrum disorder in psychiatriy. Marius Press, Carnforth, UK, pp 189-194
19. Peet M, Ramchand CN, Lee J, Telang SD, Vankar GK, Shah S, Wei J (1998) Association of the BanI dimorphic site at the human cytosolic phospholipse A2 gene with schizophrenia. Psychiatr Genet 8:191-192
20. Pettegrew JW, Keshavan MS, Panchalingan K, Strychor S, Kaplan DB, Tretta MG, Alen M (1991) Alterations in brain high-energy phosphate and membrane phospholipids metabolism in first-episode, drug naïve schizophrenics. Arc Gen Psychiatriy 48:563-568
21. Price SA, Fox H, St Clair D, Shaw DJ (1997) Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A2 gene. Psychiatr Genet 7:111-114
22. Rybakowski JK, Borkowska A, Czerski PM, Dmitrzak-Weglarz M, Hauser J (2003) The study of cytosolic phospholipase A2 gene polymorphism in schizophrenia using eye movement disturbances as an endophenotypic marker. Neuropsychobiology 47:115-119
23. Smesny S, Kinder D, Willhardt I, Rosburg T, Lasch J, Berger G, Sauer H (2005) Increased calcium-independent phospholipase A2 activity in first but not multiepisode chronic schizophrenia. Biol Psychiatry 57:399-405
24. Tao R, Yu Y, Zhang X, Guo Y, Shi J, Zhang X, Xie L, Liu S, Ju G, Xu Q, Shen Y, Wei J (2005) Cytosolic PLA2 genes possibly contribute to the etiology of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 137(1):56-58
25. Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF (2003) Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res 61:1-6
26. Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K (1995) Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics 26:138-141
27. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR (2007) Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 1:69-94
28. Wei J, Hemmings GP (2004) A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia. Prostaglandins Leukot Essent Fatty Acids 70:413-415
29. Wei J, Hemmings GP (2005) A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 73(6):441-445
30. Wei J, Lee KH, Hemmings GP (1998) Is the cPLA2 gene associated with schizophrenia? Mol Psychiatry 3:480-481
31. Yu YQ, Tao R, Wei J, Xu Q, Liu SZ, Ju GZ, Shi JP, Zhang X, Xie L, Shen Y (2004) No association between the PTGS2/PLA2G4A locus and schizophrenia in a Chinese population. Prostaglandins Leukot Essent Fatty Acids 71:405-408